185 related articles for article (PubMed ID: 38214654)
1. Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation.
Münster A; Huster J; Sommer S; Traxler C; Votteler A; Hauber W
Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38214654
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1/D2 Receptor Activity in the Nucleus Accumbens Core But Not in the Nucleus Accumbens Shell and Orbitofrontal Cortex Modulates Risk-Based Decision Making.
Mai B; Sommer S; Hauber W
Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv043. PubMed ID: 25908669
[TBL] [Abstract][Full Text] [Related]
3. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making.
St Onge JR; Abhari H; Floresco SB
J Neurosci; 2011 Jun; 31(23):8625-33. PubMed ID: 21653866
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors regulate preference between high-effort and high-risk rewards.
Gabriel DBK; Liley AE; Freels TG; Simon NW
Psychopharmacology (Berl); 2021 Apr; 238(4):991-1004. PubMed ID: 33410986
[TBL] [Abstract][Full Text] [Related]
5. Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine.
Schwager AL; Haack AK; Taha SA
Psychopharmacology (Berl); 2014 Oct; 231(20):3941-52. PubMed ID: 24647923
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic modulation of risk-based decision making.
St Onge JR; Floresco SB
Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
[TBL] [Abstract][Full Text] [Related]
7. Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.
Larkin JD; Jenni NL; Floresco SB
Psychopharmacology (Berl); 2016 Jan; 233(1):121-36. PubMed ID: 26432096
[TBL] [Abstract][Full Text] [Related]
8. Orbitofrontal or accumbens dopamine depletion does not affect risk-based decision making in rats.
Mai B; Hauber W
Cogn Affect Behav Neurosci; 2015 Sep; 15(3):507-22. PubMed ID: 25860659
[TBL] [Abstract][Full Text] [Related]
9. Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine.
Stopper CM; Khayambashi S; Floresco SB
Neuropsychopharmacology; 2013 Apr; 38(5):715-28. PubMed ID: 23303055
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic modulation of risk/reward decision making.
Montes DR; Stopper CM; Floresco SB
Psychopharmacology (Berl); 2015 Aug; 232(15):2681-96. PubMed ID: 25761840
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine.
Gozzi A; Lepore S; Vicentini E; Merlo-Pich E; Bifone A
Neuropsychopharmacology; 2013 Oct; 38(11):2120-30. PubMed ID: 23736277
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.
Schippers MC; Schetters D; De Vries TJ; Pattij T
Psychopharmacology (Berl); 2016 Jul; 233(14):2775-85. PubMed ID: 27251129
[TBL] [Abstract][Full Text] [Related]
13. Medial orbitofrontal cortex dopamine D
Jenni NL; Li YT; Floresco SB
Neuropsychopharmacology; 2021 Jun; 46(7):1240-1251. PubMed ID: 33452435
[TBL] [Abstract][Full Text] [Related]
14. Temporal Dynamics Underlying Prelimbic Prefrontal Cortical Regulation of Action Selection and Outcome Evaluation during Risk/Reward Decision-Making.
Bercovici DA; Princz-Lebel O; Schumacher JD; Lo VM; Floresco SB
J Neurosci; 2023 Feb; 43(7):1238-1255. PubMed ID: 36609453
[TBL] [Abstract][Full Text] [Related]
15. Acute stress induces selective alterations in cost/benefit decision-making.
Shafiei N; Gray M; Viau V; Floresco SB
Neuropsychopharmacology; 2012 Sep; 37(10):2194-209. PubMed ID: 22569506
[TBL] [Abstract][Full Text] [Related]
16. Anabolic-androgenic steroids (AAS) increase sensitivity to uncertainty by inhibition of dopamine D1 and D2 receptors.
Wallin-Miller KG; Kreutz F; Li G; Wood RI
Psychopharmacology (Berl); 2018 Apr; 235(4):959-969. PubMed ID: 29242988
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal Dopamine D
Jenni NL; Larkin JD; Floresco SB
J Neurosci; 2017 Jun; 37(26):6200-6213. PubMed ID: 28546312
[TBL] [Abstract][Full Text] [Related]
18. Alterations in effort-related decision-making induced by stimulation of dopamine D
Bryce CA; Floresco SB
Psychopharmacology (Berl); 2019 Sep; 236(9):2699-2712. PubMed ID: 30972447
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated yohimbine administration on reinstatement of palatable food seeking: involvement of dopamine D
Ball KT; Miller L; Sullivan C; Wells A; Best O; Cavanaugh B; Copus T; Corrigan N; Hawkins S; Kobbe K; Schoener A; Steiger J; Vieweg L
Addict Biol; 2016 Nov; 21(6):1140-1150. PubMed ID: 26223161
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic modulation of risky decision-making.
Simon NW; Montgomery KS; Beas BS; Mitchell MR; LaSarge CL; Mendez IA; Bañuelos C; Vokes CM; Taylor AB; Haberman RP; Bizon JL; Setlow B
J Neurosci; 2011 Nov; 31(48):17460-70. PubMed ID: 22131407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
